|
ZNF544 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.993980E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.202610E-01 |
| Normal-vs-Stage2 |
6.117000E-01 |
| Normal-vs-Stage3 |
1.024210E-02 |
| Normal-vs-Stage4 |
3.529700E-02 |
| Stage1-vs-Stage2 |
5.810400E-01 |
| Stage1-vs-Stage3 |
1.207380E-01 |
| Stage1-vs-Stage4 |
2.319800E-01 |
| Stage2-vs-Stage3 |
1.380240E-01 |
| Stage2-vs-Stage4 |
2.092000E-01 |
| Stage3-vs-Stage4 |
8.069200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.653920E-02 |
| Normal-vs-AfricanAmerican |
3.379400E-01 |
| Normal-vs-Asian |
6.207400E-01 |
| Caucasian-vs-AfricanAmerican |
5.933800E-01 |
| Caucasian-vs-Asian |
9.512800E-01 |
| AfricanAmerican-vs-Asian |
8.849000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.002500E-03 |
| Normal-vs-Female |
5.347200E-01 |
| Male-vs-Female |
7.722100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.142000E-02 |
| Normal-vs-Age(41-60Yrs) |
8.658200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.266400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.310400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.453400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.235200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.644400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.685400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.042000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.767000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.414400E-01 |
| Normal-vs-Grade 2 |
1.956160E-01 |
| Normal-vs-Grade 3 |
6.421200E-03 |
| Normal-vs-Grade 4 |
1.637650E-02 |
| Grade 1-vs-Grade 2 |
4.792800E-01 |
| Grade 1-vs-Grade 3 |
9.799900E-02 |
| Grade 1-vs-Grade 4 |
9.565900E-02 |
| Grade 2-vs-Grade 3 |
8.012400E-02 |
| Grade 2-vs-Grade 4 |
1.051030E-01 |
| Grade 3-vs-Grade 4 |
8.362000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.784240E-01 |
| Normal-vs-ccB subtype |
5.458000E-02 |
| ccA subtype-vs-ccB subtype |
3.957800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.215800E-02 |
| Normal-vs-N1 |
2.383800E-01 |
| N0-vs-N1 |
6.802000E-01 |
|
|
